T-helper Cell Type 17 Lineage-specific Adjuvants, Compositions And Methods

Abstract

The present invention relates to compositions and methods for the modulation of TN 17 responses. The invention provides compositions for the induction of TN 17 responses containing a TLR agonist and an apoptotic cell-associated agent or containing a microbe-infected apoptotic cell. The compositions of the present invention may also contain dendritic cells capable inducing TN 17 responses. In other embodiments, the invention provides compositions for the inhibition of TN 17 responses containing one or more blocking agents. Methods and compositions for the modulation of TN 17 responses and for the treatment of TN 17-associated diseases and for cancer are also provided.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jan 14, 2014
  • Application: Dec 9, 2009
    US US 200913133817 A
  • Priority: Dec 9, 2009
    US US 200913133817 A
  • Priority: Dec 9, 2009
    US US 2009/0067356 W
  • Priority: Dec 10, 2008
    US US 12144908 P

Download Citation


Sign in to the Lens

Feedback